Navigation Links
Titanium Group Announces Contract for Security Solution in High-End Residentials
Date:4/15/2008

ing needs; (e) the declaration and payment of dividends; and (f) the Company's ability to respond to changes in customer demand and regulations. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that the anticipated results will occur. When issued in this report, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are generally intended to identify forward-looking statements.

Important factors that could cause the actual results to differ materially from those in the forward-looking statements include, among other items, (i) changes in the regulatory and general economic environment; (ii) conditions in the capital markets, including the interest rate environment and the availability of capital; (iii) changes in the competitive marketplace that could affect the Company's revenue and/or cost and expenses, such as increased competition, lack of qualified marketing, management or other personnel, and increased labor and inventory costs; (iv) changes in technology or customer requirements, which could render the Company's technologies noncompetitive or obsolete; (v) new product introductions, product sales mix and the geographic mix of sales.

The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this advertisement are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, governmental approval processes, the impact of competitive products or pricing, technological changes, and the effect of economic conditions.
'/>"/>

SOURCE Titanium Group, Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
2. Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
3. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
4. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
5. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
6. Titanium Group Announces Contract With Haitong Securities
7. Nations and conservation groups seek plan to protect Ghost of the Himalayas
8. Group led by Stanford physicist says theres an urgent need for nuclear detectives
9. Madagascars tortoises are crawling toward extinction, groups say
10. Environmental groups call for increased protection of coral reefs
11. Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Stem cells battle for space 2Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 1Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 3Nexicon Technology to Protect Healthcare Industry 52924 1Nexicon Technology to Protect Healthcare Industry 52924 2Nexicon Technology to Protect Healthcare Industry 52924 3Nexicon Technology to Protect Healthcare Industry 52924 4Nexicon Technology to Protect Healthcare Industry 52924 5Must Haves for Your Summer Vacation Bag 52922 1Must Haves for Your Summer Vacation Bag 52922 2Must Haves for Your Summer Vacation Bag 52922 3
...(April 13, 2008, 1:00 p.m. ET) Research published ...ific inhibitors of a cell death pathway, termed ne...rotein that can direct cells into necrosis. Induce... form of necrotic death can result in tissue damag...he findings present a novel avenue for drug develo...
... to significantly boost our understanding of the f...Anglia (UEA) and the Lowestoft-based Centre for En... are launching a new strategic alliance. , The al...een the two institutions and establish exciting ne... climate change on the marine environment will inf...
... being presented today (11 April) at the UK Nation...nburgh could offer hope that bone stem cells may b...s one of the main symptoms of osteoarthritis. , S...identified stem cells within articular cartilage o... in the body like full stem cells, has the ability...
Other Biology News:Stopping unwanted cell death: Implications for drug discovery 2Stopping unwanted cell death: Implications for drug discovery 3New UEA-Cefas alliance launched 2Stem cells offer cartilage repair hope for arthritis sufferers 2
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... March 10 AutoGenomics, a leader in,developing au...ay that it,will be among the leading healthcare an...nnual Cowen Health Care Conference that will be he...Massachusetts. Fareed Kureshy,President and Chief ...company, its automated molecular testing platform ...
...sed on data previously reported, communicated in l...DGEWATER, N.J., March 7 Ortho Biotech Products, L...CRIT(R) (Epoetin alfa),following guidance from the... labeling for all drugs within the erythropoiesis-...the label were based on an unplanned interim analy...
...E, Ind. - The National Nuclear Security Administra...nt for a research center at Purdue University,s Di...ommercial and defense applications, Purdue officia...focus on the behavior and reliability of miniature...ence chosen by the NNSA. , About 35 researchers a...
Other Biology Technology:Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4
PCASMC (P350-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
BioDoc-It System from UVP
AC1 Auto System, OptiChemi™ Camera from UVP
Biology Products: